Navigation Links
Sox 18 Slows Cancers

A new gene which has the ability to slow down cancer growth has been identified by medical researchers. Cancer kills millions of people each year, and luckily tthe discovery of the new gene,called Sox 18, will help targeting the cancer of the colon, prostate,pancreas,brain and bowel.

Sox regulates blood vessel development and could be manipulated to stunt the cancer by starving the tumour cells.//

This discoverywas made by Peter Koopman and George Muscat at the University of Queensland's Institute for Molecular Bioscience.

"Tumours cannot grow above a certain size unless they attract growth of blood vessels, so by being able to control blood vessel development we may be ble to slow or stop the cancer, and the next step will be to establish which genes interact with Sox 18 to control blood vessel development and also what processes are required within cells to produce the final effects," Dr Koopman said. This gene could also be manipulated to do the reverse: to speed up blood vessel development to help heal wounds faster, and to treat circulation problems which could otherwise lead to limb amputation in diabetics. As a matter of fact this research has brought light to the scope of life of many cancer patients.
'"/>




Page: 1

Related medicine news :

1. Early Diagnosis and Treatment Slows Progression of Dementia
2. MRIs Show Drug Treatment Slows Brain Deterioration on Road to Alzheimers Disease
3. AIDS Pandemic Slows Population Growth In South Africa
4. Drug Treatment Slows Macular Vision Loss in Diabetics
5. Learning Slows Physical Progression of Alzheimers Disease: Study
6. Wearing No-line Bifocals Slows Myopia Progression in Some Children
7. Higher Physical Activity Level Slows Lung Function Decline in Smokers
8. Cancers of Colon & Rectum linked to Cigarette Smoking
9. Cancers & Reconstruction
10. Radiation Not Needed for Childhood Cancers
11. New Treatment for Some Cancers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... February 26, 2017 , ... This is an ... world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house ... is the globally recognised standard that sets out requirements for the technical competence ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a new ... B2B Sellers will now only pay for B.A.N.T. quality sales leads based on the ... said, “Given the new reality that B2B buyers are controlling the sales process via ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports improved ... study released today at the 1st Pan American Parkinson’s and Movement Disorders Congress. ... effective in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao ...
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , The New Jersey ... as well as advocacy for the state and region‘s technology businesses, hosted their ... The Council's Innovation Forecast event highlights innovation throughout the region from small to ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... AMSTERDAM , Feb. 27, 2017   ... AEX: PHIA), a global leader in health technology, ... and Drug Administration (FDA) to market its ElastQ ... EPIQ family of ultrasound systems. ElastQ Imaging enables ... stiffness, which is essential for the diagnosis of ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
(Date:2/27/2017)... 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: ... M.D., Ph.D., as President and Chief Executive Officer (CEO) and ... Dr. Craig succeeds Richard Love , interim President and ... of Directors.  Dr. Craig has over 20 years of experience ... and Europe . "On behalf ...
Breaking Medicine Technology: